These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32878291)

  • 21. Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli.
    Guo JQ; You SY; Li L; Zhang YZ; Huang JN; Zhang CY
    J Biotechnol; 2003 Apr; 102(2):177-89. PubMed ID: 12697395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of monovalent and bivalent antibody fragments in Escherichia coli.
    Grant SD; Cupit PM; Learmonth D; Byrne FR; Graham BM; Porter AJ; Harris WJ
    J Hematother; 1995 Oct; 4(5):383-8. PubMed ID: 8581373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.
    Cheung SC; Takeda S; Notkins AL
    Clin Exp Immunol; 1995 Aug; 101(2):383-6. PubMed ID: 7648724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and expression in Escherichia coli of a human gelatinase B-inhibitory single-chain immunoglobulin variable fragment (scFv).
    Zhou N; Paemen L; Opdenakker G; Froyen G
    FEBS Lett; 1997 Sep; 414(3):562-6. PubMed ID: 9323036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.
    He FT; Nie YZ; Chen BJ; Qiao TD; Fan DM; Li RF; Kang YS; Zhang Y
    World J Gastroenterol; 2002 Apr; 8(2):258-62. PubMed ID: 11925603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
    Sarker A; Rathore AS; Gupta RD
    Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity-based selection of Escherichia coli mutants for functional recombinant protein production: application to an antibody fragment.
    Belin P; Dassa J; Drevet P; Lajeunesse E; Savatier A; Boulain JC; Ménez A
    Protein Eng Des Sel; 2004 May; 17(5):491-500. PubMed ID: 15252207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of stabilized scFv antibody fragments in the E. coli bacterial cytoplasm.
    Vaks L; Benhar I
    Methods Mol Biol; 2014; 1060():171-84. PubMed ID: 24037842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced periplasmic expression of high affinity humanized scFv against Hepatitis B surface antigen by codon optimization.
    Tiwari A; Sankhyan A; Khanna N; Sinha S
    Protein Expr Purif; 2010 Dec; 74(2):272-9. PubMed ID: 20600943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of Therapeutic Single-Chain Variable Fragments (ScFv) in Pichia pastoris.
    Montoliu-Gaya L; Villegas S
    Methods Mol Biol; 2022; 2313():151-167. PubMed ID: 34478136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive.
    Kudou M; Ejima D; Sato H; Yumioka R; Arakawa T; Tsumoto K
    Protein Expr Purif; 2011 May; 77(1):68-74. PubMed ID: 21195184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning, expression and characterisation of a single-chain Fv antibody fragment against domoic acid in Escherichia coli.
    Hu X; O'Dwyer R; Wall JG
    J Biotechnol; 2005 Oct; 120(1):38-45. PubMed ID: 16019098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagents.
    Pearce LA; Oddie GW; Coia G; Kortt AA; Hudson PJ; Lilley GG
    Biochem Mol Biol Int; 1997 Sep; 42(6):1179-88. PubMed ID: 9305536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
    Sharma SK; Suresh MR; Wuest FR
    Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction and expression of single-chain antibody of neutralizing monoclonal antibody 13D8 against hepatitis E virus].
    Li LF; Luo WX; Gu Y; Zhu ZH; Wang YB; Zhang J; Xia NS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):556-9. PubMed ID: 15367346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional expression of single-chain variable fragment antibody against c-Met in the cytoplasm of Escherichia coli.
    Heo MA; Kim SH; Kim SY; Kim YJ; Chung J; Oh MK; Lee SG
    Protein Expr Purif; 2006 May; 47(1):203-9. PubMed ID: 16414274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX™ bioreactor.
    Miethe S; Meyer T; Wöhl-Bruhn S; Frenzel A; Schirrmann T; Dübel S; Hust M
    J Biotechnol; 2013 Jan; 163(2):105-11. PubMed ID: 22902410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
    Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and purification of an anti-clenbuterol single chain Fv antibody in Escherichia coli.
    Wang H; Liu X; He Y; Dong J; Sun Y; Liang Y; Yang J; Lei H; Shen Y; Xu X
    Protein Expr Purif; 2010 Jul; 72(1):26-31. PubMed ID: 20206697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of FV and Fab fragments of the antibody McPC603 expressed in E. coli.
    Plückthun A; Glockshuber R; Skerra A; Stadmüller J
    Behring Inst Mitt; 1990 Dec; (87):48-55. PubMed ID: 2096820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.